日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab

非甲状腺疾病综合征预示着接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者预后不良

Chen, I-Wen; Lin, Cheng-Wei; Lin, Po-Ting; Teng, Wei; Su, Chung-Wei; Wu, Tsung-Han; Hsieh, Yi-Chung; Chen, Wei-Ting; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis

预后营养指数预测接受阿特珠单抗和贝伐珠单抗治疗的肝细胞癌患者的预后:一项倾向评分匹配分析

Kuo, Yuan-Hung; Teng, Wei; Chen, Yen-Hao; Lin, Po-Ting; Wu, Tsung-Han; Su, Chung-Wei; Chen, Wei-Ting; Lin, Chen-Chun; Hung, Chao-Hung; Lu, Sheng-Nan; Lin, Shi-Ming; Wang, Jing-Houng; Lin, Chun-Yen

Outcomes of Liver Transplantation Without Alcohol Abstinence in Alcohol-Associated Hepatitis With Original MELD Score ≥30

酒精相关性肝炎患者在未戒酒的情况下接受肝移植的预后(初始MELD评分≥30)

Hung, Hao-Chien; Wu, Tsung-Han; Lai, Yin; Lee, Jin-Chiao; Wang, Yu-Chao; Cheng, Chih-Hsien; Lee, Chen-Fang; Wu, Ting-Jung; Chou, Hong-Shiue; Chan, Kun-Ming; Lee, Wei-Chen

Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence

树突状细胞免疫疗法在肝移植后肝细胞癌复发中的应用

Lee, Wei-Chen; Cheng, Chih-Hsien; Wu, Tsung-Han; Wang, Yu-Chao; Lee, Jin-Chiao; Hung, Hao-Chien; Lee, Chen-Fang; Wu, Ting-Jung; Chou, Hong-Shiue; Chan, Kun-Ming

Disadvantage of Viable Portal Vein Tumor Thrombosis in Liver Transplantation for Advanced Hepatocellular Carcinoma

晚期肝细胞癌肝移植中存活门静脉肿瘤血栓形成的不利影响

Chan, Kun-Ming; Lai, Yin; Hung, Hao-Chien; Lee, Jin-Chiao; Cheng, Chih-Hsien; Wang, Yu-Chao; Wu, Tsung-Han; Lee, Chen-Fang; Wu, Ting-Jung; Chou, Hong-Shiue; Lee, Wei-Chen

Moderate Immune-Related Liver Injury Is a Good Factor in Patients with Hepatoma Under Atezolizumab Plus Bevacizumab

中度免疫相关性肝损伤是接受阿特珠单抗联合贝伐珠单抗治疗的肝癌患者的良好预后因素

Wu, Tai-Chi; Lin, Po-Ting; Teng, Wei; Shen, Eric Yi-Liang; Su, Chung-Wei; Hsieh, Yi-Chung; Chen, Wei-Ting; Wu, Tsung-Han; Lin, Chen-Chun; Lin, Shi-Ming; Lin, Chun-Yen

Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population

微创肝切除术治疗早期或中期肝细胞癌患者的疗效:一项亚洲人群多中心队列研究

Chen, Hung-Kai; Chang, Kai-Cheng; Shao, Shih-Chieh; Soong, Ruey-Shyang; Chen, Yi-Chan; Wu, Chun-Feng; Wu, Tsung-Han; Chou, Tien-Shin; Chan, Siu-Cheung; Lai, Edward Chia-Cheng

Pretransplant Immune Checkpoint Inhibitor Treatment for Intermediate-advanced Hepatocellular Carcinoma in Living Donor Liver Transplantation

活体肝移植中晚期肝细胞癌的移植前免疫检查点抑制剂治疗

Cheng, Chih-Hsien; Shi, Hao-Wen; Lai, Yin; Hung, Hao-Chien; Lee, Jin-Chiao; Wang, Yu-Chao; Wu, Tsung-Han; Lee, Chen-Fang; Wu, Ting-Jung; Chou, Hong-Shiue; Chen, Tse-Ching; Chan, Kun-Ming; Lee, Wei-Chen

Does very high alpha-fetoprotein affect very early hepatocellular carcinoma receiving hepatectomy?

高甲胎蛋白水平是否会影响接受肝切除术的早期肝细胞癌患者?

Chou, Hong-Shiue; Lee, Chen-Fang; Hung, Hao-Chien; Lai, Yin; Lee, Jin-Chiao; Wang, Yu-Chao; Cheng, Chih-Hsien; Wu, Tsung-Han; Wu, Ting-Jung; Chan, Kun-Ming; Lee, Wei-Chen

Supplementation with Fish Oil and Selenium Protects Lipolytic and Thermogenic Depletion of Adipose in Cachectic Mice Treated with an EGFR Inhibitor

补充鱼油和硒可保护接受 EGFR 抑制剂治疗的恶病质小鼠的脂肪组织免受脂肪分解和产热消耗

Wang, Hang; Chan, Yi-Lin; Chiu, Yi-Han; Wu, Tsung-Han; Hsia, Simon; Wu, Chang-Jer